For 31 years, EY has produced a robust report on the global biotech industry. The 2017 Beyond Borders report moves beyond A, C, T, G—diving into digital disruption, AI, and streaming drug development. Read: ey-biotechnology-report-2017-beyond-borders-staying-the-course Most entrepreneurs consider the accelerator route as a mean to building their business—but choosing one is not a simple matter. … More Data~Facts~Reports